期刊文献+

内脂素通过过氧化体增殖物激活型受体γ信号转导通路上调酰基辅酶A∶胆固醇酰基转移酶1的表达 被引量:1

Study on Up-Regulation of the Expression of Acyl-CoA∶Cholesterol Acyltransferase1 Induced by Visfatin via Peroxisome Proliferator-Activated Receptor-γ Signal Transduction Pathway
下载PDF
导出
摘要 目的观察过氧化体增殖物激活型受体γ信号转导通路在内脂素调控人THP-1单核细胞源性巨噬细胞酰基辅酶A∶胆固醇酰基转移酶1表达中的作用,探讨内脂素诱导泡沫细胞形成的机制和途径。方法 THP-1单核细胞诱导分化为巨噬细胞,随机分组,给予不同浓度的内脂素和过氧化体增殖物激活型受体γ激动剂罗格列酮进行干预,分别运用油红O染色法观察细胞内脂滴形成情况,逆转录聚合酶链反应法和免疫印迹法检测细胞过氧化体增殖物激活型受体γ和酰基辅酶A∶胆固醇酰基转移酶1mRNA和蛋白的表达,酶荧光学法检测细胞内总胆固醇和游离胆固醇含量,总胆固醇与游离胆固醇之差为胆固醇酯含量。结果与对照组比较,内脂素组细胞内脂滴形成增加,过氧化体增殖物激活型受体γmRNA和蛋白表达水平降低(P<0.05),酰基辅酶A∶胆固醇酰基转移酶1mRNA和蛋白表达水平升高(P<0.05),细胞内胆固醇酯含量升高(P<0.05);随着内脂素浓度(10-7mol/L、10-6mol/L和10-5mol/L)升高,过氧化体增殖物激活型受体γmRNA和蛋白表达水平逐渐降低(r值分别为-0.73和-0.83,P<0.05),酰基辅酶A∶胆固醇酰基转移酶1mRNA和蛋白表达水平逐渐升高(r值分别为0.91和0.72,P<0.05)。与内脂素组比较,罗格列酮组酰基辅酶A∶胆固醇酰基转移酶1mRNA和蛋白表达水平降低(P<0.05),细胞内胆固醇酯含量降低(P<0.05);随着罗格列酮浓度(10μmol/L、15μmol/L和20μmol/L)升高,酰基辅酶A∶胆固醇酰基转移酶1mRNA和蛋白表达水平逐渐降低(r值分别为-0.69和-0.84,P<0.05)。结论内脂素呈浓度依赖性下调THP-1单核细胞源性巨噬细胞过氧化体增殖物激活型受体γ的表达,上调酰基辅酶A∶胆固醇酰基转移酶1的表达,而罗格列酮呈浓度依赖性抑制内脂素所诱导的上述效应。提示内脂素可能通过过氧化体增殖物激活型受体γ信号转导通路上调酰基辅酶A∶胆固醇酰基转移酶1 Aim To investigate the role of peroxisome proliferator-activated receptor-γ(PPARγ)signal transduction pathway in the up-regulation of the expressions of acyl-CoA:cholesterol acyltransferase 1(ACAT1)and discuss the mechanism of macrophages-derived form cell formation induced by visfatin.Methods THP-1 monocytes were induced into macrophages by 160 nmol/L phorbol myristate acetate(PMA)for 48 h,then exposed to visfatin and PPARγ activator rosiglitazone.The lipid droplet contents were observed by Oil red staining.The expressions of PPARγ and ACAT1 mRNA and protein were determined by reverse transcriptase-polymerase chain reaction(RT-PCR)and Western blotting respectively.The contents of total cholesterol(TC)and free cholesterol(FC)were detected by enzyme fluorescence analysis.Results Compared with the control group,the lipid droplet contents were increased,the expressions of PPARγ mRNA and protein were down-regulated,the expressions of ACAT1 mRNA and protein were up-regulated,and the contents of cholesterol ester(CE)were increased in visfatin groups.Compared with the visfatin group,the expressions of ACAT1 mRNA and protein were down-regulated in rosiglitazone groups.Conclusion The up-regulation of ACAT1 expression was induced by visfatin via PPARγ signal transduction pathway,which induced foam cell formation.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第10期765-769,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金(30471921)
关键词 内脂素 过氧化体增殖物激活型受体Γ 酰基辅酶A胆固醇酰基转移酶1 泡沫细胞 Visfatin Peroxisome Proliferator-Activated Receptor-γ Acyl-CoA:Cholesterol Acyltransferase 1 Foam Cell
  • 相关文献

参考文献10

  • 1Curat CA, Wegner V, Sengends C, et al. Macrophages in human visceral adipose tissue: ineressed accumulation in obesity and a source of resistin and visfatin[J]. Diabetologia, 2006, 49 (4) : 744-747. 被引量:1
  • 2Zhong M, Tan HW, Gong HP, et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis [ J ]. Clin Endocrinol Oxf, 2008, 69 (6) : 878-884. 被引量:1
  • 3Brown MS, Goldstein JL. The SREBP pathway: regulation of choleslerol metabolism by proteolysis of a membrence bond transcription factor[ J ]. Cell, 1997, 89 (3) : 331-340. 被引量:1
  • 4Cabrero A, Cubero M, Laverias G, et al. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages[J]. Metabolism, 2003, 52 (5) : 652-657. 被引量:1
  • 5Chinetti G, Lestavel S, Fruchart JC, et al. Peroxisome proliferator-activated receptor α/γ reduces cholesterol esterificatlon in macrophages [J]. Circ Re.s, 2003, 92 (2) : 212-217. 被引量:1
  • 6Gamble W, Vaughan M, Kruth HS, et al. Procedure for determination of free and total cholesterol in micro-omanogram amounts suitable for studies with cultured cells[J]. Lipid Res, 1978, 19:1 068-070. 被引量:1
  • 7何平,成蓓,王洪星,戚本玲.酰基辅酶A胆固醇酰基转移酶1基因过表达对泡沫细胞形成的影响[J].中国动脉硬化杂志,2007,15(5):325-328. 被引量:7
  • 8Barbier O, Torra IP, Duguay Y, et al. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis [J].Arterioscler Thromb Vasc Biol, 2002, 22: 717-726. 被引量:1
  • 9Kaul D, Anand PK, Khanna A. Functional genomics of PPAR-gamma in human immunomodulatory cells [ J ]. Mol Cell Biochem , 2006, 290 ( 1- 2) : 211-215. 被引量:1
  • 10刘宽芝,吕海莉,王伟超,靳陶然,温进坤,韩梅.罗格列酮对2型糖尿病大鼠大血管病变的防治作用及其分子机制[J].中国动脉硬化杂志,2006,14(2):93-96. 被引量:6

二级参考文献25

  • 1陈耀宇,管晓翔,王晓花,乐珅,柏惠,陈秀英,季勇,范乐明,陈琪.A类清道夫受体N端第1~27位氨基酸胞浆结构域缺失对功能的影响[J].中国动脉硬化杂志,2005,13(3):267-270. 被引量:5
  • 2Li Z, Li L, Zielke HR. Increased expression of 72-kd type Ⅳ collagenase (MMP-2) in human aortic atherosclerositic lesion[J]. Am J Pathol, 1996, 148: 121-128 被引量:1
  • 3Luo J, Quan J, Tsai J. Nogenetic mouse models of Non-insulin-dependent-diabetes mellitus[J]. Metabolism, 1998, 47: 663-668 被引量:1
  • 4Dollery CM. Matrix metalloproteinases and cardiovascular disease[J]. Circ Res, 1995, 77: 863-868 被引量:1
  • 5Uemura S, Matsushita H, Li W. Diabetes mellituss enhances vascular matrix metaloproteinase activity: role of oxidative stress [J]. Circ Res, 2001, 88: 1 291-298 被引量:1
  • 6Portik DV, Anstadt MP, HuTChinson J. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes[J]. Diabetes, 2002, 51: 3 036-068 被引量:1
  • 7Young PW, Buckle DR, Cantello BC. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated recepror gamma[J]. J Pharmacol Exp Ther, 1998, 284: 751-759 被引量:1
  • 8Li AC, Brown KK, Silvestre MJ. Peroxisome proliferator -activated receptor γligands inhibit development of atherosclerosis in LDL receptor-deficient mice[J]. J Clin Invest, 2000, 106: 523-531 被引量:1
  • 9]Schoonjians K, Martin G, Staels B. Peroxisome proliferator activated receptors, orphans with ligands and functions[J]. Curr Opin Lipidol, 1997, 8: 159-166 被引量:1
  • 10Staltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type Ⅱ diabetes[J]. Diabetes, 1996, 45: 1 661-669 被引量:1

共引文献11

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部